Las Vegas, NV -- (SBWIRE) -- 11/01/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Activision Blizzard, Inc. (NASDAQ:ATVI), Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR), Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Elan Corporation, plc (ADR) (NYSE:ELN)
Activision Blizzard, Inc. (NASDAQ:ATVI) managed to keep its gain at 0.42% on above-normal volume of 23.49M shares. The stock settled at $16.68 after floating in a range of $16.54 to $16.74. Its latest price has reached market capitalization of $11.60 billion. Its 52-week range has been $10.45 to $18.43. Activision, Inc. (Activision Blizzard) is a worldwide publisher of online, personal computer (PC), console, handheld, and mobile interactive entertainment products.
For How Long ATVI will fight for Profitability? Read This Trend Analysis report
Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) traded down on a volume of 20.53 million, higher than its standard daily volume. Shares have dropped-0.11% to $17.43. Over the last twelve months, the stock has lost-18.51% and faced a worst price of $12.03. Petroleo Brasileiro SA Petrobras (Petrobras) is a Brazil-based integrated oil and gas company. The Company divides its activities into six segments: Exploration and Production; Provision; Gas and Energy.
Has PBR Found The Bottom And Ready To Gain Momentum? Find Out Here
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) settled -1.62% lower at $37.09 on above-normal volume of 19.66M shares during the last trading day. The stock has its 12-month high at $42.83 and 52-week low price was $36.63. It traded in a range of $36.65 to $37.75 during the last trading day. Teva Pharmaceutical Industries Ltd (Teva) is an Israel-based pharmaceutical and drug company. It develops, produces and markets generic drugs in all treatment categories.
Will TEVA Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, Elan Corporation, plc (ADR) (NYSE:ELN) was up on high volume, trading at a volume of 19.50M versus its average daily volume of 17.02 million shares. At $16.66, the stock has attained market capitalization of 8.57 billion. Elan Corporation, plc (Elan), is a biotechnology company. The Company is focused on discovering and developing advanced therapies in neurodegenerative and autoimmune diseases.
Will ELN Continue To Move Higher? Find Out Here
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/&l...; employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)